Sensus Healthcare Issues Reminder That Its First Quarter 2024 Financial Results and Business Update Conference Call Will Be Held on Thursday, May 9, 2024
BOCA RATON, Fla., April 25, 2024 (GLOBE NEWSWIRE) -- Sensus Healthcare, Inc. (NASDAQ:SRTS), a medical device company specializing in highly effective, non-invasive treatments for both oncological and non-oncological
GlobeNewswireApr 25 08:00 ET
Sensus Healthcare to Host First Quarter 2024 Financial Results and Business Update Conference Call on Thursday, May 9, 2024
BOCA RATON, Fla. , April 18, 2024 (GLOBE NEWSWIRE) -- Sensus Healthcare, Inc. (NASDAQ:SRTS), a medical device company specializing in highly effective, non-invasive treatments for both oncological and non-oncological
GlobeNewswireApr 18 16:05 ET
Navigating Uncertainty: How Global Crises Threaten Sensus Healthcare's Growth and Operations
TipRanksMar 17 02:01 ET
Sensus Healthcare to Participate in the 36th Annual Roth Conference
Sensus Healthcare, Inc. (Nasdaq: SRTS) announces management will participate in one-on-one or small group meetings with institutional investors at the 36th Annual Roth conference to be held March 17th – 19th in Dana Point, Calif.
GlobeNewswireMar 14 16:05 ET
Sensus Healthcare Launches "Fair Deal Agreement" for Its SRT-100 Vision at the American Academy of Dermatology Annual Meeting
Sensus Healthcare, Inc. (Nasdaq: SRTS) announces the successful launch of its new "Fair Deal Agreement" for the SRT-100 Vision (IG-SRT) at the AAD 2024 Annual Meeting, held March 8-12 in San Diego.
GlobeNewswireMar 13 08:00 ET
SkinCure Oncology Unveils New Skin Cancer Treatment Technology at American Academy of Dermatology Annual Meeting in San Diego March 8-12 Booth 3555
BURR RIDGE, Ill., March 07, 2024 (GLOBE NEWSWIRE) -- SkinCure Oncology, the world leader in providing a comprehensive model for the delivery of Image-Guided Superficial Radiation Therapy (Image-Guided SRT or IGSRT) for
GlobeNewswireMar 7 16:35 ET
T2 Biosystems, AMN Healthcare Services Among Healthcare Movers
Seeking AlphaFeb 16 10:00 ET
Sensus Healthcare: Strong Q4 Performance and Promising Future Drive Buy Rating
TipRanksFeb 10 07:35 ET
Analysts Are Bullish on Top Healthcare Stocks: Foghorn Therapeutics (FHTX), Sensus Healthcare (SRTS)
TipRanksFeb 9 06:20 ET
Earnings Call: Sensus Healthcare Eyes Growth for 2024 Amid Mixed Q4 Results
InvestingFeb 9 06:00 ET
Earnings Call Summary | Sensus Healthcare(SRTS.US) Q4 2023 Earnings Conference
The following is a summary of the Sensus Healthcare, Inc. (SRTS) Q4 2023 Earnings Call Transcript:Financial Performance:Sensus Healthcare saw a decline in Q4 revenues for 2023, reporting $12.6 million
moomoo AIFeb 9 03:18 ET · Conference Call
12 Health Care Stocks Moving In Thursday's After-Market Session
GainersXilio Therapeutics (NASDAQ:XLO) shares rose 10.5% to $0.66 during Thursday's after-market session. The market value of their outstanding shares is at $18.2 million. Sensus Healthcare (NASDAQ:SR
BenzingaFeb 8 16:31 ET
Recap: Sensus Healthcare Q4 Earnings
Sensus Healthcare (NASDAQ:SRTS) reported its Q4 earnings results on Thursday, February 8, 2024 at 04:05 PM.Here's what investors need to know about the announcement.EarningsSensus Healthcare beat esti
BenzingaFeb 8 16:30 ET
Sensus Healthcare GAAP EPS of $0.26 Beats by $0.12, Revenue of $12.6M Beats by $0.54M
Seeking AlphaFeb 8 16:20 ET
Sensus Healthcare 4Q EPS 26c >SRTS
Sensus Healthcare 4Q EPS 26c >SRTS
Dow JonesFeb 8 16:05 ET
Press Release: Sensus Healthcare Reports Fourth Quarter and Full Year 2023 Financial Results
Sensus Healthcare Reports Fourth Quarter and Full Year 2023 Financial Results -- Fourth quarter revenues of $12.6 million up three-fold sequentially, reflect ongoing customer adjustment to m
Dow JonesFeb 8 16:05 ET
Sensus Healthcare Announces U.S. Patent for SRT-100 Vision System
Seeking AlphaFeb 8 09:16 ET
Express News | Sensus Healthcare Issued U.S. Patent No. 11,894,123 B2, Titled "Radiotherapy Mobile and Wireless Device Workflow Management System."
Moomoo 24/7Feb 8 08:20 ET
Earnings Scheduled For February 8, 2024
Companies Reporting Before The Bell • Ares Management (NYSE:ARES) is expected to report quarterly earnings at $1.09 per share on revenue of $864.54 million. • ArcelorMittal (NYSE:MT) is estimated to r
BenzingaFeb 8 04:43 ET
Notable Earnings After Thursday's Close
Seeking AlphaFeb 7 17:35 ET
No Data
No Data